Cognitive Benefits of Treating Sleep Apnea in Parkinson's Disease

NACompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Parkinson's DiseaseSleep Disordered Breathing
Interventions
DEVICE

Continuous positive airway pressure (CPAP)

therapeutic Continuous positive airway pressure (tCPAP) nightly for 6 weeks

DEVICE

Placebo CPAP

Ineffective Continuous positive airway pressure (pCPAP) for 3 weeks followed by therapeutic CPAP for 3 weeks

Trial Locations (1)

92093

UCSD, San Diego

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

University of California, San Diego

OTHER

NCT00492115 - Cognitive Benefits of Treating Sleep Apnea in Parkinson's Disease | Biotech Hunter | Biotech Hunter